U.S., June 18 -- ClinicalTrials.gov registry received information related to the study (NCT07654140) titled 'A Phase II Clinical Trial of Efficacy and Safety of SAL0140 at Different Doses in Patients With Uncontrolled Hypertension' on June 12.
Brief Summary: This is a multicenter, randomized, double-blind, placebo-controlled phase II study designed to explore the efficacy and safety of different doses of SAL0140 in uncontrolled hypertension.
Study Start Date: Dec. 09, 2025
Study Type: INTERVENTIONAL
Condition:
Uncontrolled Hypertension
Intervention:
DRUG: SAL0140
SAL0140 Tablets
DRUG: SAL0140
SAL0140 Tablets
DRUG: SAL0140
SAL0140 Tablets
DRUG: Placebo
Placebo
Recruitment Status: RECRUITING
Sponsor: Shenzhen Salubris Pharmace...